HANXBIO-B (03378) announced that the stabilization period relating to the global offering concluded on Saturday, January 17, 2026, which was the 30th day after the deadline for submitting applications under the Hong Kong public offering. Furthermore, the sponsor and overall coordinator, acting for itself and on behalf of the international underwriters, confirmed that the shares offered under the international offering were not over-allocated. Consequently, the over-allotment option was not exercised and lapsed on Saturday, January 17, 2026. The stabilizing agent informed the company that neither it nor any person acting on its behalf undertook any price-stabilizing actions during the stabilization period.
Comments